The COVID-19 pandemic: diverse contexts; different epidemics-how and why?


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
07 2020
Historique:
received: 07 06 2020
revised: 02 07 2020
accepted: 04 07 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 18 8 2020
Statut: ppublish

Résumé

It is very exceptional that a new disease becomes a true pandemic. Since its emergence in Wuhan, China, in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has spread to nearly all countries of the world in only a few months. However, in different countries, the COVID-19 epidemic takes variable shapes and forms in how it affects communities. Until now, the insights gained on COVID-19 have been largely dominated by the COVID-19 epidemics and the lockdowns in China, Europe and the USA. But this variety of global trajectories is little described, analysed or understood. In only a few months, an enormous amount of scientific evidence on SARS-CoV-2 and COVID-19 has been uncovered (knowns). But important knowledge gaps remain (unknowns). Learning from the variety of ways the COVID-19 epidemic is unfolding across the globe can potentially contribute to solving the COVID-19 puzzle. This paper tries to make sense of this variability-by exploring the important role that context plays in these different COVID-19 epidemics; by comparing COVID-19 epidemics with other respiratory diseases, including other coronaviruses that circulate continuously; and by highlighting the critical unknowns and uncertainties that remain. These unknowns and uncertainties require a deeper understanding of the variable trajectories of COVID-19. Unravelling them will be important for discerning potential future scenarios, such as the first wave in virgin territories still untouched by COVID-19 and for future waves elsewhere.

Identifiants

pubmed: 32718950
pii: bmjgh-2020-003098
doi: 10.1136/bmjgh-2020-003098
pmc: PMC7392634
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : DBT-Wellcome Trust India Alliance
ID : IA/CPHI/16/1/502648
Pays : India

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nature. 2020 Mar;579(7797):18-19
pubmed: 32127703
Clin Vaccine Immunol. 2010 Dec;17(12):1875-80
pubmed: 20943876
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
World J Pediatr. 2020 Jun;16(3):267-270
pubmed: 32180140
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Clin Infect Dis. 2011 Apr 1;52(7):911-6
pubmed: 21427399
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
J Pediatr. 1965 Mar;66:471-88
pubmed: 14264306
Am J Dis Child. 1962 Mar;103:255-61
pubmed: 13859385
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Proc Am Philos Soc. 2006 Mar;150(1):86-112
pubmed: 17526158
Clin Infect Dis. 2010 Nov 15;51(10):1176-83
pubmed: 20942655
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Lancet. 2020 May 16;395(10236):1527-1529
pubmed: 32353328
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
Osong Public Health Res Perspect. 2020 Apr;11(2):74-80
pubmed: 32257772
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
PLoS One. 2016 Apr 27;11(4):e0153003
pubmed: 27119988
Sci Rep. 2019 Feb 20;9(1):2348
pubmed: 30787335
Science. 2020 May 8;368(6491):
pubmed: 32234805
Clin Infect Dis. 2021 May 4;72(9):e412-e414
pubmed: 32687149
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32010938
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Lancet. 2020 Mar 28;395(10229):1015-1018
pubmed: 32197103
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32350047
Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721):
pubmed: 28396469
Respirology. 2003 Nov;8 Suppl:S2-5
pubmed: 15018125
J Med Virol. 2020 Jun;92(6):667-674
pubmed: 32167180
J Infect. 2020 Jun;80(6):e32-e33
pubmed: 32209383
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Emerg Infect Dis. 2006 Jan;12(1):15-22
pubmed: 16494711
Wellcome Open Res. 2020 May 1;5:83
pubmed: 32656368
Int J Biol Sci. 2020 Mar 15;16(10):1686-1697
pubmed: 32226286
Virol J. 2010 Mar 04;7:52
pubmed: 20202190
Environ Sci Technol Lett. 2020 May 20;7(7):511-516
pubmed: 37566285
BMJ Glob Health. 2020 May;5(5):
pubmed: 32444364
Nature. 2020 Sep;585(7825):410-413
pubmed: 32365354
Clin Infect Dis. 2020 Nov 19;71(16):2230-2232
pubmed: 32266381
J Theor Biol. 2022 May 7;540:111063
pubmed: 35189135
Euro Surveill. 2020 Mar;25(12):
pubmed: 32234121
N Engl J Med. 2020 Mar 26;382(13):1268-1269
pubmed: 32109011
Int J Antimicrob Agents. 2020 Jun;55(6):106006
pubmed: 32371096
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451366
Lancet. 2020 Feb 29;395(10225):676
pubmed: 32113495
Elife. 2020 Apr 02;9:
pubmed: 32228860
N Engl J Med. 2009 Jul 9;361(2):115-9
pubmed: 19474418
J Med Virol. 2020 Sep;92(9):1549-1555
pubmed: 32196707
Bull World Health Organ. 1992;70(6):741-4
pubmed: 1486670
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Sci Rep. 2020 Oct 12;10(1):17002
pubmed: 33046802
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
Math Biosci. 2002 Nov-Dec;180:29-48
pubmed: 12387915
Lancet. 2020 May 30;395(10238):1715-1725
pubmed: 32405103
Lancet Infect Dis. 2012 Sep;12(9):687-95
pubmed: 22738893
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Trop Med Int Health. 2000 Aug;5(8):511-4
pubmed: 10995091
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):533-534
pubmed: 32246939
Philos Trans R Soc Lond B Biol Sci. 1996 Dec 29;351(1348):1679-88
pubmed: 9004320
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Lancet Infect Dis. 2020 Aug;20(8):920-928
pubmed: 32422201
Clin Infect Dis. 2020 Jul 28;71(15):861-862
pubmed: 32201889
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
N Engl J Med. 2010 May 6;362(18):1708-19
pubmed: 20445182
JAMA Netw Open. 2020 Jun 1;3(6):e2011834
pubmed: 32525550
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Hum Vaccin Immunother. 2020 Jul 2;16(7):1659-1667
pubmed: 32017650
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759
SN Compr Clin Med. 2020;2(4):383-387
pubmed: 32296757
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304
Nat Med. 2020 Apr;26(4):502-505
pubmed: 32284613
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Wim Van Damme (W)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium wvdamme@itg.be.

Ritwik Dahake (R)

Independent Researcher, Bengaluru, India.

Alexandre Delamou (A)

Africa Centre of Excellence for Prevention and Control of Transmissible Diseases, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.

Brecht Ingelbeen (B)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.

Edwin Wouters (E)

Department of Sociology and Centre for Population, University of Antwerp, Antwerpen, Belgium.
Centre for Health Systems Research and Development, University of the Free State-Bloemfontein Campus, Bloemfontein, Free State, South Africa.

Guido Vanham (G)

Biomedical Department, Institute of Tropical Medicine, Antwerpen, Belgium.
Biomedical Department, University of Antwerp, Antwerpen, Belgium.

Remco van de Pas (R)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.

Jean-Paul Dossou (JP)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.
Public Health, Centre de recherche en Reproduction Humaine et en Démographie, Cotonou, Benin.

Por Ir (P)

National Institute of Public Health, Phnom Penh, Cambodia.

Seye Abimbola (S)

School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
The George Institute for Global Health, Sydney, New South Wales, Australia.

Stefaan Van der Borght (S)

Board Member, Institute of Tropical Medicine, Antwerpen, Belgium.

Devadasan Narayanan (D)

Health Systems Transformation Platform, New Delhi, India.

Gerald Bloom (G)

Health and Nutrition Cluster, Institute of Development Studies, Brighton, UK.

Ian Van Engelgem (I)

European Commission Directorate General for Civil Protection and Humanitarian Aid Operations, Kinshasa, Democratic Republic of Congo.

Mohamed Ali Ag Ahmed (MA)

University of Sherbrooke, Sherbrooke, Quebec, Canada.

Joël Arthur Kiendrébéogo (JA)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.
Public Health, University of Ouagadougou Health Sciences Training and Research Unit, Ouagadougou, Burkina Faso.
Heidelberg Institute of Global Health, Medical Faculty and University Hospital, Heidelberg University, Heidelberg, Germany.

Kristien Verdonck (K)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.

Vincent De Brouwere (V)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.

Kéfilath Bello (K)

Public Health, Centre de recherche en Reproduction Humaine et en Démographie, Cotonou, Benin.

Helmut Kloos (H)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

Peter Aaby (P)

INDEPTH Network, Bandim Health Project, Bissau, Guinea-Bissau.

Andreas Kalk (A)

Bureau GIZ à Kinshasa, Kinshasa, Democratic Republic of Congo.

Sameh Al-Awlaqi (S)

Center for International Health Protection, Robert Koch Institute, Berlin, Germany.

N S Prashanth (NS)

Health Equity Cluster, Institute of Public Health, Bengaluru, India.

Jean-Jacques Muyembe-Tamfum (JJ)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.

Placide Mbala (P)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.

Steve Ahuka-Mundeke (S)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.

Yibeltal Assefa (Y)

School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH